Clinical Trial Update: TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz [Phase 2]

View source ↗

Summary

This Phase 2 pharmacokinetic study reports on the intermittent rifabutin and isoniazid regimens co-administered with daily efavirenz in individuals with HIV inf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Drugs mentioned

• EFAVIRENZ (efavirenz)
• ISONIAZID (ISONIAZID)
• RIFABUTIN (Rifabutin)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: HIV Infections, Tuberculosis | Phase 2 | Status: COMPLETED